302 related articles for article (PubMed ID: 24922660)
21. In Vitro Validation of Intratumoral Modulation Therapy for Glioblastoma.
Xu HU; Bihari F; Whitehead S; Wong E; Schmid S; Hebb MO
Anticancer Res; 2016 Jan; 36(1):71-80. PubMed ID: 26722029
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
[TBL] [Abstract][Full Text] [Related]
23. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells.
Tian T; Li A; Lu H; Luo R; Zhang M; Li Z
Biochem Biophys Res Commun; 2015 Aug; 463(4):638-43. PubMed ID: 26043698
[TBL] [Abstract][Full Text] [Related]
24. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
[TBL] [Abstract][Full Text] [Related]
25. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.
Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H
Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310
[TBL] [Abstract][Full Text] [Related]
27. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines.
Oancea-Castillo LR; Klein C; Abdollahi A; Weber KJ; Régnier-Vigouroux A; Dokic I
Cancer Biol Ther; 2017 Jun; 18(6):400-406. PubMed ID: 28494176
[TBL] [Abstract][Full Text] [Related]
29. Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma.
Kiang KM; Tang W; Song Q; Liu J; Li N; Lam TL; Shum HC; Zhu Z; Leung GK
Br J Cancer; 2023 May; 128(10):1955-1963. PubMed ID: 36927978
[TBL] [Abstract][Full Text] [Related]
30. Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.
McFaline-Figueroa JL; Braun CJ; Stanciu M; Nagel ZD; Mazzucato P; Sangaraju D; Cerniauskas E; Barford K; Vargas A; Chen Y; Tretyakova N; Lees JA; Hemann MT; White FM; Samson LD
Cancer Res; 2015 Aug; 75(15):3127-38. PubMed ID: 26025730
[TBL] [Abstract][Full Text] [Related]
31. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.
Furuta T; Sabit H; Dong Y; Miyashita K; Kinoshita M; Uchiyama N; Hayashi Y; Hayashi Y; Minamoto T; Nakada M
Oncotarget; 2017 Apr; 8(14):22811-22824. PubMed ID: 28423558
[TBL] [Abstract][Full Text] [Related]
32. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
Triscott J; Lee C; Hu K; Fotovati A; Berns R; Pambid M; Luk M; Kast RE; Kong E; Toyota E; Yip S; Toyota B; Dunn SE
Oncotarget; 2012 Oct; 3(10):1112-23. PubMed ID: 23047041
[TBL] [Abstract][Full Text] [Related]
33. Activation of the Unfolded Protein Response via Inhibition of Protein Disulfide Isomerase Decreases the Capacity for DNA Repair to Sensitize Glioblastoma to Radiotherapy.
Liu Y; Ji W; Shergalis A; Xu J; Delaney AM; Calcaterra A; Pal A; Ljungman M; Neamati N; Rehemtulla A
Cancer Res; 2019 Jun; 79(11):2923-2932. PubMed ID: 30996048
[TBL] [Abstract][Full Text] [Related]
34. Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells.
Epple LM; Dodd RD; Merz AL; Dechkovskaia AM; Herring M; Winston BA; Lencioni AM; Russell RL; Madsen H; Nega M; Dusto NL; White J; Bigner DD; Nicchitta CV; Serkova NJ; Graner MW
PLoS One; 2013; 8(8):e73267. PubMed ID: 24039668
[TBL] [Abstract][Full Text] [Related]
35. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
Chen TC; Wang W; Golden EB; Thomas S; Sivakumar W; Hofman FM; Louie SG; Schönthal AH
Cancer Lett; 2011 Mar; 302(2):100-8. PubMed ID: 21257259
[TBL] [Abstract][Full Text] [Related]
36. Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.
Lefranc F; James S; Camby I; Gaussin JF; Darro F; Brotchi J; Gabius J; Kiss R
J Neurosurg; 2005 Apr; 102(4):706-14. PubMed ID: 15871514
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic TRADD confers a worse prognosis in glioblastoma.
Chakraborty S; Li L; Tang H; Xie Y; Puliyappadamba VT; Raisanen J; Burma S; Boothman DA; Cochran B; Wu J; Habib AA
Neoplasia; 2013 Aug; 15(8):888-97. PubMed ID: 23908590
[TBL] [Abstract][Full Text] [Related]
38. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme.
Fisher T; Galanti G; Lavie G; Jacob-Hirsch J; Kventsel I; Zeligson S; Winkler R; Simon AJ; Amariglio N; Rechavi G; Toren A
Cancer J; 2007; 13(5):335-44. PubMed ID: 17921733
[TBL] [Abstract][Full Text] [Related]
40. ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis.
Weatherbee JL; Kraus JL; Ross AH
Oncotarget; 2016 Jul; 7(28):43820-43834. PubMed ID: 27286262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
